Colony Group LLC Edwards Lifesciences Corp Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Colony Group LLC holds 13,398 shares of EW stock, worth $877,301. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,398

Previous 14,122 5.13%

Holding current value

$877,301

Previous $1.33 Million 30.33%

% of portfolio

0.01%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $50,158 - $67,607	-724 Reduced 5.13%	13,398 $928,000
Q2 2023 Aug 15, 2023	BUY	$81.41 - $94.33 $5,780 - $6,697	71 Added 0.51%	14,122 $1.33 Million
Q1 2023 May 16, 2023	SELL	$74.26 - $84.51 $52,873 - $60,171	-712 Reduced 4.82%	14,051 $1.16 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $20,626 - $26,406	-302 Reduced 2.0%	14,763 $1.1 Million
Q3 2022 Nov 15, 2022	BUY	$82.37 - $107.29 $570,741 - $743,412	6,929 Added 85.16%	15,065 $1.25 Million
Q2 2022 Aug 16, 2022	SELL	$86.5 - $128.27 $570,554 - $846,068	-6,596 Reduced 44.77%	8,136 $774,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $68,313 - $85,987	-670 Reduced 4.35%	14,732 $1.73 Million
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $34,570 - $42,471	-325 Reduced 2.07%	15,402 $2 Million
Q2 2021 Aug 18, 2021	BUY	$83.84 - $104.76 $49,800 - $62,227	594 Added 3.93%	15,727 $1.63 Million
Q1 2021 May 21, 2021	SELL	$78.68 - $90.67 $7,631 - $8,794	-97 Reduced 0.64%	15,133 $1.27 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $23,155 - $29,467	323 Added 2.17%	15,230 $1.39 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $632,249 - $845,526	10,988 Added 280.38%	14,907 $1.03 Million
Q1 2020 May 18, 2020	SELL	$52.41 - $81.0 $37,158 - $57,429	-709 Reduced 15.32%	3,919 $739,000
Q4 2019 Feb 18, 2020	BUY	$71.7 - $82.09 $32,265 - $36,940	450 Added 10.77%	4,628 $1.08 Million
Q3 2019 Nov 26, 2019	BUY	$61.55 - $75.43 $25,727 - $31,529	418 Added 11.12%	4,178 $919,000
Q2 2019 Aug 19, 2019	SELL	$55.74 - $64.41 $2.52 Million - $2.91 Million	-45,214 Reduced 92.32%	3,760 $695,000
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $19,826 - $26,516	-414 Reduced 0.84%	48,974 $9.37 Million
Q4 2018 Feb 15, 2019	SELL	$46.41 - $56.94 $2,691 - $3,302	-58 Reduced 0.12%	49,388 $7.57 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $62,791 - $79,733	-1,374 Reduced 2.7%	49,446 $8.61 Million
Q2 2018 Aug 15, 2018	BUY	$42.45 - $51.3 $652,753 - $788,840	15,377 Added 43.39%	50,820 $7.4 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $1.32 Million - $1.68 Million	35,443 New	35,443 $4.95 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account